Discrepancy in BPH Treatment Prices May Not Reflect Efficacy

Discrepancy in BPH Treatment Prices May Not Reflect Efficacy
Despite the fact that there is a 400% discrepancy between the cheapest and most expensive health care methods to treat benign prostate hyperplasia (BPH), there are in fact no differences in its effectiveness. Those are the conclusions of new research conducted at the University of California – Los Angeles, which analyzed for the first time the costs

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *